Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.96 USD
Change Today +0.29 / 2.72%
Volume 1.5M
FOLD On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter M. Macaluso

Vice President, Corporate Counsel and Secretary, Amicus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

38--

Background*

Mr. Peter M. Macaluso has been a General Counsel and Corporate Secretary at Houghton International Inc., since November 2013 and serves as its Senior Vice President. Mr. Macaluso served as Vice President at Houghton International Inc., since November 2013. He joined Houghton in November 2013. Before joining Houghton, Mr. Macaluso served as Vice President and Corporate Counsel at Amicus Therapeutics, Inc. since February 2013 and served as its Secretary since May 2012. ...

Read Full Background

Corporate Headquarters*

1 Cedar Brook Drive
Cranbury, New Jersey 08512

United States

Phone: 609-662-2000
Fax: 609-662-2001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
University of Michigan
JD
Boston University School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $10.96 USD +0.29

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.